vTv Therapeutics Inc.
VTVT
$21.96
-$0.78-3.43%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Revenue | 11,011.11% | 11,011.11% | 5,455.56% | -- | -99.55% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 11,011.11% | 11,011.11% | 5,455.56% | -- | -99.55% |
| Cost of Revenue | -24.06% | -29.26% | -41.39% | -27.09% | -17.26% |
| Gross Profit | 33.23% | 38.25% | 48.92% | 12.86% | 2.27% |
| SG&A Expenses | 15.51% | 8.39% | 19.95% | -2.41% | -19.84% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -7.93% | -13.15% | 5.10% | 3.84% | -2.08% |
| Operating Income | 11.58% | 16.76% | -0.92% | -13.14% | -5.57% |
| Income Before Tax | 18.13% | -3.12% | -21.88% | -4.39% | 2.30% |
| Income Tax Expenses | -- | -- | -- | -- | -100.00% |
| Earnings from Continuing Operations | 17.77% | -3.53% | -22.35% | -3.56% | 2.99% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -27.80% | -3.45% | 17.37% | -3.27% | -12.84% |
| Net Income | 14.92% | -5.51% | -23.78% | -5.67% | -0.22% |
| EBIT | 11.58% | 16.76% | -0.92% | -13.14% | -5.57% |
| EBITDA | 11.62% | 16.81% | -0.93% | -13.20% | -5.59% |
| EPS Basic | 26.47% | 3.35% | -13.80% | 6.84% | 15.79% |
| Normalized Basic EPS | 29.33% | 8.94% | -5.79% | -45.48% | -26.18% |
| EPS Diluted | 26.47% | 3.35% | -13.80% | 6.84% | 15.79% |
| Normalized Diluted EPS | 29.33% | 8.94% | -5.79% | -45.48% | -26.18% |
| Average Basic Shares Outstanding | 15.33% | 9.93% | 10.06% | 11.46% | 16.55% |
| Average Diluted Shares Outstanding | 15.33% | 9.93% | 10.06% | 11.46% | 16.55% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
